January 28, 2025 · Form 4 insider transaction
Robinson Chandler bought 62,815 shares of MONOPAR THERAPEUTICS INC at $0.00 per share, a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 367 days after the transaction.
Pro rata liquidating distribution from Tactic Pharma, LLC ("Tactic"), of which the reporting person is a non-controlling member. In prior reports, the reporting person reported beneficial ownership of 272,026 shares of Monopar Therapeutics Inc. common stock held by Tactic.; Represents shares held by the Chandler D. Robinson Irrevocable Trust U/A dated May 20, 2020.